Kyowa Kirin’s Poteligeo provides progression-free survival in CTCL trial
Kyowa Kirin has reported that the MAVORIC trial of Poteligeo (mogamulizumab) in patients with mycosis fungoides (MF) and Sézary syndrome…
Scotland
Latest in
Scotland
Coronavirus: COVID-19 UK outbreak, measures and impact
The UK confirmed its first 2019-nCoV (now COVID-19) infection case, following France and Germany, on 31 January 2020 and has…